The Institute Of Molecular And Translational Medicine, Czech Republic
Clinical trials sponsored by The Institute Of Molecular And Translational Medicine, Czech Republic, explained in plain language.
-
Could an alcoholism drug plus copper fight breast cancer?
Disease control CompletedThis Phase 2 trial tested whether disulfiram (Antabuse), a drug used for alcoholism, combined with copper supplements could help people with metastatic breast cancer who had run out of standard options. Only 9 patients took part, and researchers measured tumor response and surviv…
Phase: PHASE2 • Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Olomouc study reveals how many have COVID antibodies
Knowledge-focused CompletedThis study looked at nearly 2,500 adults in the Olomouc region to find out how many had antibodies or cellular immunity against the SARS-CoV-2 virus, either from a past infection or from vaccination. Participants gave blood samples and answered a questionnaire. The goal was to un…
Phase: NA • Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC